Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Superinvestors holding ORIC, Q2 2026
1 superinvestor reports holding Oric Pharmaceuticals, Inc. on Form 13F, worth $55.5M in total. Weight is Oric Pharmaceuticals, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | 0.2% | 5,126,762 | $55.5M | Reduced−12.0% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ORIC each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−12.0%)
Q1 2026
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−11.4%)
Q4 2025
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (0.0%)
Q1 2025
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+48.3%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+10.8%)
Q1 2024
1 superinvestor holding at quarter end